Aclarubicin (INN) or aclacinomycin A is an anthracycline drug that is used in the treatment of cancer in China. It was previously approved for use in Europe but was discontinued in 2004 due to being rarely prescribed and unprofitable.
via PubMed
Aclarubicin (INN) or aclacinomycin A is an anthracycline drug that is used in the treatment of cancer in China. It was previously approved for use in Europe but was discontinued in 2004 due to being rarely prescribed and unprofitable.
However, it has subsequently been reevaluated due to possible advantages over other chemotherapeutic drugs in the treatment of certain cancers such as acute myeloid leukemia.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).